These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1302216)

  • 81. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
    Bier H
    HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
    [No Abstract]   [Full Text] [Related]  

  • 82. [The treatment of solid tumors with monoclonal antibodies].
    Dippold WG; Meyer zum Büschenfelde KH
    Immun Infekt; 1989 Feb; 17(1):26-7. PubMed ID: 2925221
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Experimental radioimmunotherapy: biological effectiveness and comparison with external beam radiation.
    Buchsbaum DJ; Roberson PL
    Recent Results Cancer Res; 1996; 141():9-18. PubMed ID: 8722417
    [No Abstract]   [Full Text] [Related]  

  • 84. Monoclonal antibodies for radioimmunoscintigraphy of breast cancer.
    Merino MJ; Monteagudo C; Neumann RD
    Int J Rad Appl Instrum B; 1991; 18(4):437-43. PubMed ID: 1650767
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Colonic metastases of a calcified ovarian cystadenocarcinoma].
    Baillet P; Nouel O; Rouanet JP; Lichtenstein H; Bloch P
    Nouv Presse Med; 1977 Oct; 6(33):2992. PubMed ID: 593837
    [No Abstract]   [Full Text] [Related]  

  • 86. Cancer therapy using radioimmunoconjugates. Implications for breast cancer.
    Tempero M; Colcher D; Dalrymple G; Harrison K; Holdeman K; Joshi S; Quadri S; Linder J; Augustine S; Reed E
    Ann N Y Acad Sci; 1993 Nov; 698():406-17. PubMed ID: 8279780
    [No Abstract]   [Full Text] [Related]  

  • 87. CA 72.4 serum levels in 298 patients with non-malignant diseases.
    Sagredo E; Soriano A; Pombo L; Roiz MC; Allende MT; Ruibal A
    Int J Biol Markers; 1989; 4(2):125. PubMed ID: 2768890
    [No Abstract]   [Full Text] [Related]  

  • 88. Pretargeted Radioimmunotherapy of Ovarian Cancer with
    Li X; Lan X; Cai W
    J Nucl Med; 2023 Sep; 64(9):1446-1448. PubMed ID: 37591542
    [No Abstract]   [Full Text] [Related]  

  • 89. Treatment of gastrointestinal cancer using monoclonal antibodies.
    Markoe AM; Brady LW; Woo D; Amendola B; Karlsson U; Fisher S; Micaily B; Rackover M; Bulova S; Steplewski Z
    Front Radiat Ther Oncol; 1990; 24():214-24; discussion 225-7. PubMed ID: 2187759
    [No Abstract]   [Full Text] [Related]  

  • 90. Radioiodinated monoclonal antibodies.
    Mather SJ
    Int J Biochem; 1988; 20(8):759-68. PubMed ID: 3049179
    [No Abstract]   [Full Text] [Related]  

  • 91. Isotopic labelling of a specific antibody.
    TEKMAN S; DALGLIESH CE
    Br J Exp Pathol; 1954 Apr; 35(2):118-21. PubMed ID: 13149731
    [No Abstract]   [Full Text] [Related]  

  • 92. ZIF-8 with cationic defects toward efficient
    Tian XX; Liu YT; Li Y; Qiu XY; Zhang WH; Young DJ; Chen Q
    Chem Commun (Camb); 2022 Jun; 58(49):6942-6945. PubMed ID: 35640157
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [L9, a novel and promising monoclonal antibody against Malaria].
    Cools T; Jeanpierre M; Soulard V
    Med Sci (Paris); 2021; 37(8-9):807-811. PubMed ID: 34491193
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
    Mittal BB; Zimmer MA; Sathiaseelan V; Benson AB; Mittal RR; Dutta S; Rosen ST; Spies SM; Mettler JM; Groch MW
    Cancer; 1996 Nov; 78(9):1861-70. PubMed ID: 8909304
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
    Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM
    J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
    Schmiegel WH; Kalthoff H
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
    [No Abstract]   [Full Text] [Related]  

  • 99. [The treatment of colonic and ovarian cancer with radioactive monoclonal antibodies against the CA l9-9 and CA 125 antigens].
    Graef A; Romero MA; González M; Pierzo JA; Sosa R; Altamirano P
    Gac Med Mex; 1992; 128(2):91-5. PubMed ID: 1302216
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.